Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)
Germany · Delayed Price · Currency is EUR 1.110
+0.020 (1.83%)
At close: Nov 27, 2025
FRA:UJ9 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 32.03 | 73.19 | -119.38 | -331.75 | -225.42 | -240.54 |
Depreciation & Amortization | 56.52 | 44.96 | 59.45 | 57.35 | 40.63 | 15.88 |
Other Amortization | 27.95 | 27.95 | 23.31 | 15.48 | 9.38 | - |
Loss (Gain) From Sale of Assets | - | - | - | 0.02 | 0.07 | 0.01 |
Stock-Based Compensation | 17.85 | 21.5 | 20.64 | 18.48 | 21.28 | - |
Provision & Write-off of Bad Debts | 6.95 | 2.17 | -0.03 | 0.03 | - | - |
Other Operating Activities | 39.46 | 33.11 | 15.76 | 5.12 | 7.45 | 10.62 |
Change in Accounts Receivable | -163.67 | -179.58 | -60.21 | -104.88 | -106.57 | 5 |
Change in Inventory | 27.41 | -2.96 | -21.66 | -44.79 | -79.17 | -17.12 |
Change in Accounts Payable | -25.52 | -3.98 | 57.37 | 21.49 | 47.13 | 52.44 |
Change in Unearned Revenue | -0.27 | 2.34 | 3 | -1.8 | -1 | 1.6 |
Change in Other Net Operating Assets | 57.64 | -136.64 | 3.17 | 163.42 | 39.95 | -334.63 |
Operating Cash Flow | 76.33 | -117.94 | -18.57 | -201.84 | -246.28 | -506.72 |
Capital Expenditures | -32.35 | -66.6 | -67.32 | -81.29 | -107.73 | -25.05 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - |
Sale (Purchase) of Intangibles | -229.19 | -296.31 | -227.43 | -125.09 | -233.52 | -106.22 |
Investment in Securities | - | - | - | 100 | -100 | - |
Other Investing Activities | -0.27 | - | 1.19 | 5.69 | 8.95 | 112.49 |
Investing Cash Flow | -261.8 | -362.89 | -293.57 | -100.68 | -432.3 | -18.79 |
Short-Term Debt Issued | - | 1.44 | 1.37 | - | 2.83 | 886.08 |
Long-Term Debt Issued | - | 421.92 | 132.85 | 52.98 | - | - |
Total Debt Issued | 313.1 | 423.36 | 134.22 | 52.98 | 2.83 | 886.08 |
Short-Term Debt Repaid | - | - | - | - | - | -659.08 |
Long-Term Debt Repaid | - | -147.08 | -37.03 | -18.61 | -9.43 | -486.22 |
Total Debt Repaid | -193.21 | -147.08 | -37.03 | -18.61 | -9.43 | -1,145 |
Net Debt Issued (Repaid) | 119.9 | 276.28 | 97.19 | 34.37 | -6.6 | -259.22 |
Issuance of Common Stock | 591.55 | 229.53 | - | 189.16 | 1,230 | 798.27 |
Other Financing Activities | -38.14 | -27.98 | 185.89 | -223.66 | -11.89 | -11.82 |
Financing Cash Flow | 673.3 | 477.83 | 283.09 | -0.13 | 1,212 | 527.23 |
Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -2.6 | 4.45 | -5.08 | - |
Net Cash Flow | 487.84 | -2.98 | -31.65 | -298.21 | 528.07 | 1.73 |
Free Cash Flow | 43.98 | -184.53 | -85.89 | -283.13 | -354.01 | -531.77 |
Free Cash Flow Margin | 5.81% | -25.41% | -13.89% | -54.87% | -223.06% | - |
Free Cash Flow Per Share | 0.08 | -0.34 | -0.17 | -0.57 | -0.74 | -13.55 |
Cash Interest Paid | 38.14 | 27.98 | 14.11 | 13.05 | 11.6 | 11.82 |
Levered Free Cash Flow | -250.06 | -586.09 | -77.35 | -484.93 | -801.42 | - |
Unlevered Free Cash Flow | -225.32 | -565.68 | -68.55 | -476.55 | -794.17 | - |
Change in Working Capital | -104.41 | -320.81 | -18.33 | 33.44 | -99.66 | -292.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.